Part, Chapter, Paragraph
1 -, 1 | Data sources; (iii) Data description and analysis; (iv) Risk
2 I, 2. 10. 1| outcomes which lead to the description of groups individual prevention
3 II, 5. 2. 3| 5.2.3. Data description and analysis~ ~
4 II, 5. 4. 3| 5.4.3 Data description and analysis~ ~Comparable
5 II, 5. 4. 8| Diabetes Network: a brief description, Diabetes Nutrition and
6 II, 5. 5. 1| 5.5.1.3. Data description and analysis~ ~Prevalence,
7 II, 5. 5. 2| 5.5.2.3. Data description and analysis~ ~Prevalence~ ~
8 II, 5. 5. 3| Bulimia has a similar description in the DSMR-IV classification.
9 II, 5. 5. 3| 5.5.3.1.3. Data description and analysis~ ~Reviewed
10 II, 5. 5. 3| 5.5.3.2.3. Data description and analysis~ ~Data usually
11 II, 5. 5. 3| to be the comprehensive description of the gap between what
12 II, 5. 5. 3| Kanner’s first clinical description with the intention to develop
13 II, 5. 5. 3| 5.5.3.3.3. Data description and analysis~ ~Cross-sectional
14 II, 5. 5. 3| 5.5.3.4.3. Data description and analysis~ ~In Europe,
15 II, 5. 5. 3| 5.5.3.5.3. Data description and analysis~ ~Nearly 200
16 II, 5. 5. 3| 5.5.3.6.3. Data description and analysis~ ~Morbidity
17 II, 5. 6. 3| 5.6.3. Data description and analysis~ ~The major
18 II, 5. 7. 1| Severity and Therapy~ ~ ~Stage~Description~GFR*~(mL/min per 1.73 m2 )~
19 II, 5. 7. 3| 5.7.3. Data description and analysis~ ~Incidence~ ~
20 II, 5. 8. 3| 5.8.3. Data description and analysis~ ~This section
21 II, 5. 9. 3| 5.9.3. Data description and analysis~ ~Incidence
22 II, 5. 9. 6| for achieving a complete description of asthma, focused not only
23 II, 5. 10. 2| Union~ ~ ~ ~Code~Diagnostic description~ICD-9~693.1~Dermatitis due
24 II, 5. 10. 3| 5.10.3. Data description and analysis~ ~Prevalence
25 II, 5. 11. 3| 5.11.3. Data description and analysis~ ~Diseases
26 II, 5. 12. 3| 5.12.3. Data description and analysis~ ~Graphic representations
27 II, 5. 14. 2| major reason is that the description of periodontal condition
28 II, 5. 14. 3| 5.14.3 Data description and analysis~ ~Dental caries~ ~
29 II, 5. 15. 3| 5.15.3. Data description and analysis~ ~The distribution
30 II, 6. 3 | 6.3. Data description and analysis~ ~
31 II, 8. 2. 1| 8.2.1.3. Data description and analysis~ ~Prevalence~ ~
32 II, 8. 2. 2| 8.2.2.3. Data Description~ ~A review and selection,
33 II, 8. 2. 3| 8.2.3.3. Data description~ ~Prevalence of congenital
34 II, 9. 1. 2| 9.1.2.3. Data description and analysis~ ~Prevalence
35 II, 9. 2. 3| 9.2.3. Data description and analysis~ ~Infants and
36 II, 9. 3. 1| 9.3.1.3. Data description and analysis~ ~Premature
37 II, 9. 3. 2| of registration) and case description. Improvement of ascertainment
38 II, 9. 4. 3| 9.4.3. Data description and analysis~ ~ ~By the
39 II, 9. 5. 3| 9.5.3. Data description and analysis~ ~Health inequalities~ ~
40 III, 10. 2. 1| 10.2.1.1.3. Data description and analysis~ ~Prevalence
41 III, 10. 2. 1| 10.2.1.2.3. Data description and analysis~Alcohol consumption
42 III, 10. 2. 1| advertising to the mere description of the product without any
43 III, 10. 2. 1| 10.2.1.3.3. Data description and analysis~ ~Overall estimates
44 III, 10. 2. 1| treatments in some regions.~The description of the drug situation presented
45 III, 10. 2. 1| 10.2.1.5.3. Data description and analysis~ ~The Burden
46 III, 10. 2. 1| 10.2.1.6.3. Data description and analysis~ ~An analysis
47 III, 10. 2. 1| 10.2.1.7.3. Data description and analysis~ ~Overweight
48 III, 10. 2. 4| outcomes which lead to the description of groups with a significant
49 III, 10. 2. 4| 10.2.4.3. Data description and analysis~ ~In the past
50 III, 10. 2. 5| 10.2.5.3. Data description and analysis~ ~The Barker
51 III, 10. 3. 1| 10.3.1.3. Data description and analysis~ ~Radon~ ~Current
52 III, 10. 3. 4| 10.3.4.3. Data description and analysis~ ~Climatic
53 III, 10. 4. 1| 10.4.1.3. Data description and analysis~ ~Air pollution
54 III, 10. 4. 2| 10.4.2.3. Data description and analysis~ ~Several years
55 III, 10. 4. 4| identify. For a detailed description of contact dermatitis associated
56 III, 10. 4. 5| Agency (EEA) (2008).~ ~Data description and analysis~ ~ ~At present,
57 III, 10. 4. 5| available on http ~ ~Data description and analysis~ ~Waste production~ ~
58 III, 10. 5. 1| 10.5.1.3. Data description and analysis~ ~As human
59 III, 10. 5. 2| 10.5.2.3. Data description and analysis.~ ~Demographic
60 III, 10. 5. 3| 10.5.3.3 Data description and analysis~The burden
61 III, 10. 6. 1| 10.6.1.3. Data description and analysis~ ~Data on social
62 III, 10. 6. 2| 10.6.2.3. Data description and analysis~ ~Among the
63 III, 10. 6. 3| 10.6.3.3. Data description and analysis~ ~Homicides:
64 IV, 11. 6. 2| 11.6.2. Description and assessment of health
65 IV, 11. 6. 4| 11.6.4. Description of arrangements for pooling
66 IV, 11. 6. 4| allocation of funds, and description of the resource allocation
67 IV, 12. 2 | permitted advertising to description of the product without any
68 IV, 12. 5 | European Council, 2002). A description of the main activities and
69 IV, 12. 5 | In the following a brief description of the ECHI-System is given.
